LIFEVANTAGE CORP Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
LIFEVANTAGE CORP (LFVN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 100.00 thousand shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-27
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 200.00K shares.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-12-31 was 200.00K shares, a 100.00% increase year-over-year.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 200.00K shares, a 33.33% decline year-over-year.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 100.00K shares, a 233.33% increase from fiscal 2025.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 30.00K shares, a 130.77% increase from fiscal 2024.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 13.00K shares, a 93.50% decline from fiscal 2023.
- LIFEVANTAGE CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 200.00K shares, a 0.00% change from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 100.00K shares 10-K · filed 2026-08-27 | ||||||
| 2026-03-31 | 200.00K shares 10-Q · filed 2026-05-06 | 200.00K shares 10-Q · filed 2026-05-06 | |||||
| 2025-12-31 | 200.00K shares 10-Q · filed 2026-02-04 | 200.00K shares 10-Q · filed 2026-02-04 | |||||
| 2025-09-30 | 200.00K shares 10-Q · filed 2025-11-04 | ||||||
| 2025-06-30 | 30.00K shares 10-K · filed 2026-08-27 | ||||||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-06 | 100.00K shares 10-Q · filed 2026-05-06 | |||||
| 2024-12-31 | 100.00K shares 10-Q · filed 2026-02-04 | 100.00K shares 10-Q · filed 2026-02-04 | |||||
| 2024-09-30 | 300.00K shares 10-Q · filed 2025-11-04 | ||||||
| 2024-06-30 | 13.00K shares 10-K · filed 2025-09-04 | ||||||
| 2024-03-31 | 8.00K shares 10-Q · filed 2025-05-06 | 34.00K shares 10-Q · filed 2025-05-06 | |||||
| 2023-12-31 | 26.00K shares 10-Q · filed 2025-02-05 | 100.00K shares 10-Q · filed 2025-02-05 | |||||
| 2023-09-30 | 300.00K shares 10-Q · filed 2024-10-29 | ||||||
| 2023-06-30 | 200.00K shares 10-K · filed 2024-08-28 | ||||||
| 2023-03-31 | 100.00K shares 10-Q · filed 2024-05-02 | 300.00K shares 10-Q · filed 2024-05-02 | |||||
| 2022-12-31 | 200.00K shares 10-Q · filed 2024-01-30 | 400.00K shares 10-Q · filed 2024-01-30 | |||||
| 2022-09-30 | 600.00K shares 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | 200.00K shares 10-K · filed 2023-08-28 | ||||||
| 2022-03-31 | 100.00K shares 10-Q · filed 2023-05-04 | 200.00K shares 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | 100.00K shares 10-Q · filed 2023-02-02 | 200.00K shares 10-Q · filed 2023-02-02 | |||||
| 2021-09-30 | 200.00K shares 10-Q · filed 2022-11-02 | ||||||
| 2021-06-30 | 100.00K shares 10-K · filed 2022-08-23 | ||||||
| 2021-03-31 | 100.00K shares 10-Q · filed 2022-05-03 | 50.00K shares 10-Q · filed 2021-04-29 | 100.00K shares 10-Q · filed 2022-05-03 | ||||
| 2020-12-31 | 45.00K shares 10-Q · filed 2022-02-01 | 100.00K shares 10-Q · filed 2022-02-01 | |||||
| 2020-09-30 | 200.00K shares 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | 100.00K shares 10-K · filed 2022-08-23 | ||||||
| 2020-03-31 | 9.00K shares 10-Q · filed 2021-04-29 | 100.00K shares 10-Q · filed 2021-04-29 | |||||
| 2019-12-31 | 100.00K shares 10-Q · filed 2021-02-02 | 200.00K shares 10-Q · filed 2021-02-02 | |||||
| 2019-09-30 | 21.00K shares 10-Q · filed 2020-11-03 | ||||||
| 2019-06-30 | 200.00K shares 10-K · filed 2021-08-19 | ||||||
| 2019-03-31 | 18.00K shares 10-Q · filed 2020-05-05 | 300.00K shares 10-Q · filed 2020-05-05 | |||||
| 2018-12-31 | 100.00K shares 10-Q · filed 2020-01-28 | 200.00K shares 10-Q · filed 2020-01-28 | |||||
| 2018-09-30 | 9.00K shares 10-Q · filed 2019-10-30 | ||||||
| 2018-06-30 | 400.00K shares 10-K · filed 2020-08-18 | ||||||
| 2018-03-31 | 500.00K shares 10-Q · filed 2019-05-01 | 600.00K shares 10-Q · filed 2019-05-01 | |||||
| 2017-12-31 | 100.00K shares 10-Q · filed 2019-02-04 | 300.00K shares 10-Q · filed 2019-02-04 | |||||
| 2017-09-30 | 200.00K shares 10-Q · filed 2018-11-01 | ||||||
| 2017-06-30 | 200.00K shares 10-K · filed 2019-08-14 | ||||||
| 2017-03-31 | 200.00K shares 10-Q · filed 2018-05-09 | 100.00K shares 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | 100.00K shares 10-Q · filed 2018-02-07 | 43.00K shares 10-Q · filed 2018-02-07 | |||||
| 2016-09-30 | 46.00K shares 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | 200.00K shares 10-K · filed 2017-09-07 | ||||||
| 2016-03-31 | 100.00K shares 10-Q · filed 2017-05-10 | 200.00K shares 10-Q · filed 2017-05-10 | |||||
| 2015-12-31 | 200.00K shares 10-Q · filed 2017-02-08 | 200.00K shares 10-Q · filed 2017-02-08 | |||||
| 2015-09-30 | 500.00K shares 10-Q · filed 2016-12-12 | ||||||
| 2015-06-30 | 400.00K shares 10-K · filed 2016-12-12 | 3.10M shares 10-K · filed 2015-09-01 | |||||
| 2015-03-31 | 400.00K shares 10-Q/A · filed 2016-07-19 | 2.80M shares 10-Q · filed 2015-05-06 | 300.00K shares 10-Q/A · filed 2016-07-19 | 2.30M shares 10-Q · filed 2015-05-06 | |||
| 2014-12-31 | 400.00K shares 10-Q · filed 2016-02-09 | 600.00K shares 10-Q · filed 2016-02-09 | |||||
| 2014-09-30 | 300.00K shares 10-Q · filed 2015-11-04 | ||||||
| 2014-06-30 | 300.00K shares 10-K · filed 2015-09-01 | ||||||
| 2014-03-31 | 2.10M shares 10-Q · filed 2015-05-06 | 900.00K shares 10-Q · filed 2015-05-06 | |||||
| 2013-12-31 | 600.00K shares 10-Q · filed 2015-02-04 | 700.00K shares 10-Q · filed 2015-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |